Ticker Details
Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients.
IPO Date:	February 22, 2000
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$513.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 4.36%
Avg Daily Range (30 D):	$0.25 | 3.78%
Avg Daily Range (90 D):	$0.23 | 3.62%

Institutional Daily Volume
Avg Daily Volume:	5.15M
Avg Daily Volume (30 D):	.6M
Avg Daily Volume (90 D):	.7M

Trade Size
Avg Trade Size (Sh.):	450
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	462
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$.94M
Avg Institutional Trade (90 D):	$2.08M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.36M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$2.76M
Avg Closing Volume:	111.38K

News

Jul 14, 2026 @ 4:30 AM Global Blood Glucose Monitoring System Market Size... Source: Custom Market Insights

May 1, 2026 @ 1:50 AM Senseonics Announces Pricing of $80 Million Public... Source: Na

Apr 29, 2026 @ 8:31 AM Middle East and Africa Continuous Glucose Monitori... Source: Researchandmarkets.Com

Apr 24, 2026 @ 11:00 AM Senseonics Announces European Launch of EversenseÃ... Source: Na

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.63	$-.71	$-.47
Diluted EPS	$-.63	$-.71	$-.47
Revenue	$14.48M	$11.71M	$14.26M
Gross Profit	$8.56M	$6.94M	$7.67M
Net Income / Loss	$-36.71M	$-32.33M	$-20.82M
Operating Income / Loss	$-35.99M	$-31.85M	$-20.93M
Cost of Revenue	$5.92M	$4.77M	$6.59M
Net Cash Flow	$15.14M	$-10.62M	$5.78M
PE Ratio

Splits
Oct 20, 2025	1:20
Nov 10, 2015	12:1